Works matching IS 20050380 AND DT 2023 AND VI 34 AND IP 2
Results: 15
Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e51
- By:
- Publication type:
- Article
Incidence and treatment outcomes of uterine cervical cancer in Korea 1999-2018 from the national cancer registry.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e39
- By:
- Publication type:
- Article
Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT).
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e37
- By:
- Publication type:
- Article
Levonorgestrel-releasing intrauterine system-based therapies for earlystage endometrial cancer: a systematic review and meta-analysis.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e36
- By:
- Publication type:
- Article
The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women's cancer research organization.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e33
- By:
- Publication type:
- Article
Low-grade endometrial stromal sarcoma with intravenous thrombus extension: a multidisciplinary surgical challenge.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e21
- By:
- Publication type:
- Article
Risk factors for and delayed recognition of genitourinary fistula following radical hysterectomy for cervical cancer: a population-based analysis.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e20
- By:
- Publication type:
- Article
CircSMAD2 accelerates endometrial cancer cell proliferation and metastasis by regulating the miR-1277-5p/MFGE8 axis.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e19
- By:
- Publication type:
- Article
Lymphocyte activation gene (LAG)-3 is a potential immunotherapeutic target for microsatellite stable, programmed death-ligand 1 (PD-L1)-positive endometrioid endometrial cancer.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e18
- By:
- Publication type:
- Article
Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e17
- By:
- Publication type:
- Article
Number of FoxP3+ regulatory T-cells are associated with recurrence in vulvar squamous cell carcinoma.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e16
- By:
- Publication type:
- Article
A phase II, open-label, non-randomized, prospective study assessing paclitaxel, carboplatin and metformin in the treatment of advanced stage ovarian carcinoma.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e15
- By:
- Publication type:
- Article
Validation of HPV triage in cytology-based cervical cancer screening for ASC-US cases using Japanese data.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e14
- By:
- Publication type:
- Article
Intraoperative frozen pathology exam of Common iliac lymph nodes and Para-Aortic lymphadenectomy on the prognosis and quality of life for patients with IB2-IIA2 Cervical Cancer: trial protocol for a randomized controlled trial (C-PACC trial).
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e13
- By:
- Publication type:
- Article
Fertility and prognosis assessment between bleomycin/etoposide/cisplatin and paclitaxel/carboplatin chemotherapy regimens in the conservative treatment of malignant ovarian germ cell tumors: a multicenter and retrospective study.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e12
- By:
- Publication type:
- Article